Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
IEEE Transactions on Cybernetics|July 12, 2018
Distributed Adaptive Event-Triggered Fault-Tolerant Consensus of Multiagent Systems With General Linear DynamicsDan Ye, Meng-Meng Chen, Hai-Jiao YangInternational Journal of Molecular Sciences|October 20, 2019
Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung CancerYi-Ming Li, Jing-Min Yu, Zhen-Yu Liu, et al.CNS Neuroscience & Therapeutics|May 14, 2021
Endothelial genetic deletion of CD147 induces changes in the dual function of the blood-brain barrier and is implicated in Alzheimer's diseaseHao Wang, Jian-Jun Lv, Yu Zhao, et al.Hepatology (Baltimore, Md.)|April 26, 2019
Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 AxisYi-Ming Li, Zhen-Yu Liu, Jian-Chao Wang, et al.International Journal of Molecular Sciences|January 6, 2019
Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3Yi-Ming Li, Zhen-Yu Liu, Zhu-Chun Li, et al.Oncotarget|October 27, 2015
CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinomaJuan Tang, Yun-Shan Guo, Xiao-Ling Yu, et al.Theranostics|July 9, 2019
RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppressionZhen-Yu Liu, Ming Zheng, Yi-Ming Li, et al.Journal for Immunotherapy of Cancer|July 25, 2025
hCCL19-expressing recombinant Newcastle disease virus boosts CAR T cell infiltration and efficacy in solid tumorMan Liu, Can Li, Lan-Ting Feng, et al.Cancer Letters|June 6, 2022
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemiaNai-Shan Zheng, Xiang-Yu Zhao, Ding Wei, et al.Pageof 1